TH17 cells may be a potential biomarker to predict the risk of immune-related adverse events in patients with metastatic ...

Rahul Banerjee, MD, FACP, assistant professor in the Division of Hematology and Oncology, University of Washington, dissects the limited data on T-cell therapies for multiple myeloma, infectious ...

Investigators have developed a way to 'supercharge' T cells by supplying them with extra mitochondria from multipotent stromal cells.

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

Scientists at UNIGE and HUG have developed CAR-T cells capable of targeting malignant gliomas while preserving healthy tissue ...

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective. In ...

Tocilizumab -- an interleukin (IL)-6 receptor inhibitor -- was approved by the FDA in 2017 for the treatment of severe or ...

Gentler saltwater pools are becoming the norm and not the exception. Here's what you need to know about converting a pool.

Neuroblastoma (NB), a cancer arising in the adrenal gland or less often from the extra-adrenal sympathetic chain, including in the retroperitoneum, chest, and neck, represents the most common solid ...

Plus, Europe’s great battery hope scrambles to raise funds and an ugly boardroom brawl to kick out a billionaire founder ...

Last November, longtime Claremont resident Lou Berrio was diagnosed with acute myeloid leukemia, a type of cancer that tricks ...

Explore the story of Dominican-American poet and novelist Julia Alvarez, who burst onto the literary scene and blazed a trail for a generation of Latino authors.